Dolutegravir Tablet 50 mg

Here is a complete overview of Dolutegravir Tablet 50 mg with icons:


πŸ’Š Dolutegravir Tablet 50 mg


πŸ§ͺ Nature / Drug Class

πŸ”Ή Antiretroviral Agent
πŸ”Ή Integrase Strand Transfer Inhibitor (INSTI)
πŸ”Ή Inhibits HIV enzyme integrase, preventing viral replication


🩺 Purpose / Indications

βœ… Used in the treatment of HIV-1 infection, including:

  • 🧬 First-line therapy in adults and adolescents
  • πŸ” Switch therapy from other ART regimens
  • πŸ›‘οΈ Part of post-exposure prophylaxis (PEP)

βš™οΈ Advantages

βœ”οΈ Potent viral suppression
βœ”οΈ High genetic barrier to resistance
βœ”οΈ Once-daily dosing in most cases
βœ”οΈ Effective in naΓ―ve and treatment-experienced patients
βœ”οΈ Fewer drug interactions than older agents


πŸ“¦ Common Packaging

πŸ“¦ Tablet: 50 mg
πŸ’Š Supplied in blister packs or bottles of 30 tablets
🧴 Often part of fixed-dose combinations with other ARTs (e.g., with Lamivudine & Tenofovir)


⚠️ Patient Advice / Precautions

πŸ• Usually taken once daily
🍽️ Can be taken with or without food
πŸ’€ May cause insomnia, headache, or mild dizziness
🚫 Avoid taking antacids, calcium, or iron within 2 hours (interferes with absorption)
πŸ‘©β€πŸΌ Considered safe in pregnancy, but requires medical guidance
🧬 Not for monotherapy – always use in combination with other ARTs


🧊 Storage

🌑️ Store at room temperature
🚫 Protect from moisture and direct sunlight
πŸ§’ Keep out of reach of children


Leave a Comment

Your email address will not be published. Required fields are marked *

Call Now Button